Ranbaxy Hit With Class Action Over Generic Lipitor Recall
Ranbaxy Inc. was hit with a putative class action filed in New Jersey federal court last week, alleging the company's recall of its generic version of blockbuster cholesterol treatment Lipitor did...To view the full article, register now.
Already a subscriber? Click here to view full article